AGP Limited (PSX:AGP)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
182.99
-1.36 (-0.74%)
At close: Apr 28, 2026
-12.94%
Market Cap 51.62B
Revenue (ttm) 28.89B
Net Income (ttm) 3.74B
Shares Out 280.00M
EPS (ttm) 13.34
PE Ratio 13.82
Forward PE 11.62
Dividend 8.00 (4.34%)
Ex-Dividend Date Apr 13, 2026
Volume 73,124
Average Volume 612,780
Open 182.07
Previous Close 184.35
Day's Range 179.01 - 183.95
52-Week Range 142.00 - 258.67
Beta 0.42
RSI 46.15
Earnings Date Apr 29, 2026

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1989
Employees 2,143
Stock Exchange Pakistan Stock Exchange
Ticker Symbol AGP
Full Company Profile

Financial Performance

In 2025, AGP Limited's revenue was 28.89 billion, an increase of 15.40% compared to the previous year's 25.03 billion. Earnings were 3.74 billion, an increase of 39.91%.

Financial Statements

News

There is no news available yet.